These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9834947)

  • 1. Preliminary investigations in matrix-based tablet formulations of diltiazem hydrochloride containing succinic acid-treated methylcellulose.
    Gohel MC; Patel MM; Chhabaria MT; Buaria CP
    Pharm Dev Technol; 1998 Nov; 3(4):453-9. PubMed ID: 9834947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of drug release rate of diltiazem-HCl from hydrogel matrices of succinic acid-treated ispaghula husk.
    Gohel MC; Amin AF; Chhabaria MT; Panchal MK; Lalwani AN
    Pharm Dev Technol; 2000; 5(3):375-81. PubMed ID: 10934737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two different approaches for the prediction of in vivo plasma concentration-time profile from in vitro release data of once daily formulations of diltiazem hydrochloride.
    Bendas ER
    Arch Pharm Res; 2009 Sep; 32(9):1317-29. PubMed ID: 19784589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies in release behavior of diltiazem HCl from matrix tablets containing (hydroxypropyl)methyl cellulose and xanthan gum.
    Gohel MC; Amin AF; Patel KV; Panchal MK
    Boll Chim Farm; 2002; 141(1):21-8. PubMed ID: 12064053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M.
    Qazi F; Shoaib MH; Yousuf RI; Qazi TM; Mehmood ZA; Hasan SM
    Pak J Pharm Sci; 2013 Jul; 26(4):653-63. PubMed ID: 23811439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivariate statistical approach to optimizing sustained-release tablet formulations containing diltiazem hydrochloride as a model highly water-soluble drug.
    Kikuchi S; Takayama K
    Int J Pharm; 2010 Feb; 386(1-2):149-55. PubMed ID: 19922778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accessibility of solid core tablet for dissolution in an asymmetric triple-layer matrix system.
    Yang L; Fassihi R
    J Pharm Pharmacol; 2003 Oct; 55(10):1331-7. PubMed ID: 14607013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
    al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
    Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in vitro dissolution profile of dual polymer (Eudragit RS100 and RL100) microparticles of diltiazem hydrochloride.
    Das SK; Das NG
    J Microencapsul; 1998; 15(4):445-52. PubMed ID: 9651866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
    Vostalová L; Rabisková M; Medvecká G
    Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and in vitro evaluation of a novel combined multiparticulate delayed-onset sustained-release formulation of diltiazem hydrochloride.
    Chen S; Zhu J; Cheng J
    Pharmazie; 2007 Dec; 62(12):907-13. PubMed ID: 18214341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
    Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and in vitro testing of a floatable gastroretentive tablet of metformin hydrochloride.
    Basak SC; Rahman J; Ramalingam M
    Pharmazie; 2007 Feb; 62(2):145-8. PubMed ID: 17341036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging--effect of solubility of additives on HPMC matrix tablets.
    Tajarobi F; Abrahmsén-Alami S; Carlsson AS; Larsson A
    Eur J Pharm Sci; 2009 May; 37(2):89-97. PubMed ID: 19429415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
    Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
    Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pumps.
    Prabakaran D; Singh P; Kanaujia P; Vyas SP
    Int J Pharm; 2003 Jun; 259(1-2):173-9. PubMed ID: 12787645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zero-order release of aspirin, theophylline and atenolol in water from novel methylcellulose glutarate matrix tablets.
    Khairuzzaman A; Ahmed SU; Savva M; Patel NK
    Int J Pharm; 2006 Aug; 318(1-2):15-21. PubMed ID: 16621361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diltiazem Hydrochloride Floating Matrix Tablet: Formulation and
    Koradia KD; Jotaniya BK; Koradia HD
    Cardiovasc Hematol Disord Drug Targets; 2024; 24(2):110-124. PubMed ID: 39034726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alginate-diltiazem hydrochloride beads: optimization of formulation factors, in vitro and in vivo availability.
    El-Kamel AH; Al-Gohary OM; Hosny EA
    J Microencapsul; 2003; 20(2):211-25. PubMed ID: 12554376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.